Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
28.30
+0.57 (2.06%)
At close: Jun 13, 2025, 4:00 PM
27.06
-1.24 (-4.38%)
After-hours: Jun 13, 2025, 7:26 PM EDT

KNSA Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Revenue
481.17423.24270.26220.1838.54-
Upgrade
Revenue Growth (YoY)
59.45%56.61%22.75%471.24%--
Upgrade
Cost of Revenue
219.5189.2289.9346.979.94-
Upgrade
Gross Profit
261.67234.02180.33173.2128.61-
Upgrade
Selling, General & Admin
172.86168.01129.4397.9585.9545.32
Upgrade
Research & Development
104.61111.6276.165.4999.3112.04
Upgrade
Operating Expenses
277.47279.63205.52163.44185.25157.36
Upgrade
Operating Income
-15.8-45.62-25.29.77-156.64-157.36
Upgrade
Other Non Operating Income (Expenses)
9.499.468.541.250.11.13
Upgrade
Pretax Income
-6.31-36.15-16.6511.03-156.54-156.23
Upgrade
Income Tax Expense
10.647.04-30.74-172.341.395.15
Upgrade
Net Income
-16.95-43.1914.08183.36-157.92-161.38
Upgrade
Net Income to Common
-16.95-43.1914.08183.36-157.92-161.38
Upgrade
Net Income Growth
---92.32%---
Upgrade
Shares Outstanding (Basic)
727170696962
Upgrade
Shares Outstanding (Diluted)
727172706962
Upgrade
Shares Change (YoY)
-0.30%-0.69%2.13%2.69%10.89%14.42%
Upgrade
EPS (Basic)
-0.24-0.600.202.64-2.30-2.61
Upgrade
EPS (Diluted)
-0.24-0.600.202.60-2.30-2.61
Upgrade
EPS Growth
---92.31%---
Upgrade
Free Cash Flow
43.7325.4113.175.7-126.71-136.82
Upgrade
Free Cash Flow Per Share
0.610.360.180.08-1.85-2.21
Upgrade
Gross Margin
54.38%55.29%66.72%78.67%74.22%-
Upgrade
Operating Margin
-3.28%-10.78%-9.32%4.44%-406.38%-
Upgrade
Profit Margin
-3.52%-10.21%5.21%83.28%-409.72%-
Upgrade
Free Cash Flow Margin
9.09%6.00%4.87%2.59%-328.75%-
Upgrade
EBITDA
-14.23-43.92-22.8612.18-154.28-154.96
Upgrade
EBITDA Margin
-2.96%-10.38%-8.46%5.53%--
Upgrade
D&A For EBITDA
1.571.72.342.42.362.41
Upgrade
EBIT
-15.8-45.62-25.29.77-156.64-157.36
Upgrade
EBIT Margin
-3.28%-10.78%-9.32%4.44%--
Upgrade
Revenue as Reported
481.17423.24270.26220.1838.54-
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q